The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts

Free Radical Biology and Medicine

Volumn 49, Issue 1, 2010, Pages 88-95

  Lang, Yaw Dong ^a   Hung, Chien Lung ^a,b   Wu, Tzu Ying ^a   Wang, Leng Fang ^a   Chen, Chung Ming ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b AsiaRice Biotch Inc   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Smooth muscle actin; Angiotensin II; Angiotensin II type 1 receptor; Angiotensin converting enzyme; Hyperoxia; Lung fibroblasts

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN; COLLAGEN TYPE 1; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; ACTA2 PROTEIN, HUMAN; ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HYPEROXIA; LUNG FIBROBLAST; LUNG FIBROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; GENETICS; LUNG; METABOLISM; PATHOLOGY;

ACTINS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CELLS, CULTURED; COLLAGEN TYPE I; FIBROBLASTS; HUMANS; HYPEROXIA; IMIDAZOLES; LOSARTAN; LUNG; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS;

EID: 77953028657     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.03.022     Document Type: Article

References (27)

1. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L.A., Stoll B.J., Verter J., Temprosa M., Wright L.L. Ehrenkranz RA, Fanaroff, A. A.; Stark, A.; Carlo, W.; Tyson, J. E.; Donovan, E. F.; Shankaran, S.; Stevenson, D. K. Very low birth weight outcomes of the National Institute of Child Health and Human Development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001, 107:E1.
2. Northway W.H., Moss R.B., Carlisle K.B., Parker B.R., Popp R.L., Pitlick P.T., Eichler I., Lamm R.L., Brown B.W. Late pulmonary sequelae of bronchopulmonary dysplasia. N. Engl. J. Med. 1990, 323:1793-1799.
3. Merritt T.A., Deming D.D., Boynton B.R. The 'new' bronchopulmonary dysplasia: challenges and commentary. Semin. Fetal Neonatal Med. 2009, 14:345-357.
4. Cho H.Y., Kleeberger S.R. Genetic mechanisms of susceptibility to oxidative lung injury in mice. Free Radic. Biol. Med. 2007, 42:433-445.
5. Bose C.L., Dammann C.E., Laughon M.M. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch. Dis. Child Fetal Neonatal Ed. 2008, 93:F455-F461.
6. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 1977, 57:313-370.
7. Bullock G.R., Steyaert I., Bilbe G., Carey R.M., Kips J., De Paepe B., Pauwels R., Praet M., Siragy H.M., de Gasparo M. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem. Cell Biol. 2001, 115:117-124.
8. Cassis L., Shenoy U., Lipke D., Baughn J., Fettinger M., Gillespie M. Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 1997, 54:27-31.
9. Specks U., Martin W.J., Rohrbach M.S. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am. Rev. Respir. Dis. 1990, 141:117-123.
10. Filippatos G., Tilak M., Pinillos H., Uhal B.D. Regulation of apoptosis by angiotensin II in the heart and lungs. Int. J. Mol. Med. 2001, 7:273-280.
11. Marshall R.P., McAnulty R.J., Laurent G.J. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med. 2000, 161:1999-2004.
12. Chen C.M., Wang L.F., Chou H.C., Lang Y.D., Lai Y.P. Up-regulation of connective tissue growth factor in hyperoxia-induced lung fibrosis. Pediatr. Res. 2007, 62:128-133.
13. Cairns J.A., Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 1997, 99:1313-1321.
14. Scotton C.J., Chambers R.C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321.
15. Marshall R.P., Gohlke P., Chambers R.C., Howell D.C., Bottoms S.E., Unger T., McAnulty R.J., Laurent G.J. Angiotensin II and the fibroproliferative response to acute lung injury. Am. J. Physiol. 2004, 286:L156-L164.
16. Waseda Y., Yasui M., Nishizawa Y., Inuzuka K., Takato H., Ichikawa Y., Tagami A., Fujimura M., Nakao S. Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice. Respir. Res. 2008, 9:43.
17. Li Z., Carter J.D., Dailey L.A., Huang Y.C. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type 1 receptor. Environ. Health Perspect. 2005, 113:1009-1014.
18. Molina-Molina M., Serrano-Mollar A., Bulbena O., Fernandez-Zabalegui L., Closa D., Marin-Arguedas A., Torrego A., Mullol J., Picado C., Xaubet A. Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis. Thorax 2006, 61:604-610.
19. Bellmeyer A., Martino J.M., Chandel N.S., Scott Budinger G.R., Dean D.A., Mutlu G.M. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am. J. Respir. Crit. Care Med. 2007, 175:587-594.
20. Kirk J.M., Heard B.E., Kerr I., Turner-Warwick M., Laurent G.J. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Collagen Rel. Res. 1984, 4:169-182.
21. Hussain N., Wu F., Christian C., Kresch M.J. Hyperoxia inhibits fetal rat lung fibroblast proliferation and expression of procollagens. Am. J. Physiol. 1997, 273:L726-L732.
22. Pendergrass K.D., Gwathmey T.M., Michalek R.D., Grayson J.M., Chappell M.C. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem. Biophys. Res. Commun. 2009, 384:149-154.
23. Re R.N. Implications of intracrine hormone action for physiology and medicine. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H751-H757.
24. Tharaux P.L., Chatziantoniou C., Fakhouri F., Dussaule J.C. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 2000, 36:330-336.
25. Rehan V., Torday J. Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem. Biophys. 2003, 38:239-250.
26. Zhang K., Rekhter M.D., Gordon D., Phan S.H. Co-expression of α-smooth muscle actin and type I collagen in fibroblast-like cells of rat lungs with bleomycin-induced pulmonary fibrosis: a combined immuno-histochemical and in situ hybridization study. Am. J. Pathol. 1994, 145:114-125.
27. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.